Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives

Front Oncol. 2023 Jan 25:12:1115342. doi: 10.3389/fonc.2022.1115342. eCollection 2022.

Authors

Alberto Zambelli^{1

2}, Maurizio D'Incalci¹

Affiliations

¹ Department of Biomedical Sciences, Humanitas University, Milan, Italy.
² Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy.

No abstract available

Keywords: eribulin and related compounds; lurbinectedin; marine drugs; solid tumor; trabectedin.

Publication types

Editorial